Rezvan Yazdian-Robati

Viittaukset

	Kaikki	2020 lähtien
Sitaatit	2491	2121
h-indeksi	30	27
i10-indeksi	53	51

480

240

120

360

20172018201920202021202220232024202556 128 169 252 370 479 450 472 95

Yleisessä käytössä

Näytä kaikki

1 artikkeli

2 artikkelia

käytettävissä

ei käytettävissä

Perustuu rahoitusehtoihin

Muut kirjoittajat

Khalil AbnousPharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, IranVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
Seyed Mohammad TaghdisiProfessor, Department of Pharmaceutical Biotechnology, Mashhad University of Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
maryam hashemiAssociate profess of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of MedicalVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
Majid SaeediProfessor of Pharmaceutics, Mazandaran University of Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa mazums.ac.ir
hossein hosseinzadehProfessor of Pharmacodynamy and Toxicology, Mashhad University of Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
payam bayatVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
Najmeh AnsariMashhad university of medical scienceVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
Mahin Shahdordizadehmolecular department of Food and Drug Administration of Mashhad University Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
Amirhossein BahreyniDepartment of Pathology and Laboratory Medicine, UBC Center for Heart Lung Innovation, St. Paul'sVahvistettu sähköpostiosoite verkkotunnuksessa hli.ubc.ca
Seyed Hamid Jalalian, Pharm.D.Pharm.D., PhD., Pharmaceutical Research Center, Pharmaceutical Technology Institute, MashhadVahvistettu sähköpostiosoite verkkotunnuksessa mums.ac.ir
Marzieh RashediniaAssociate Professor of Pharmacology-Toxicology, Shiraz University of Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa sums.ac.ir
Javad BehravanUniversity of WaterlooVahvistettu sähköpostiosoite verkkotunnuksessa uwaterloo.ca
Fahimeh CharbgooDWI - Leibniz-Institut für Interaktive MaterialienVahvistettu sähköpostiosoite verkkotunnuksessa dwi.rwth-aachen.de
Mohammad RamezaniXProf of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences

Seuraa

Rezvan Yazdian-Robati

Muut nimetRezvan Yazdian

Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran

Vahvistettu sähköpostiosoite verkkotunnuksessa mazums.ac.ir

aptamer aptasensor nanomedicine targeted drug delivery


Nimike Lajittele sitaattien mukaan Lajittele vuoden mukaan Lajittele otsikon mukaan	Viittaukset Viittaukset	Vuosi
Therapeutic applications of AS1411 aptamer, an update review R Yazdian-Robati, P Bayat, F Oroojalian, M Zargari, M Ramezani, ... International journal of biological macromolecules 155, 1420-1431, 2020	216	2020
Recent advances in nanotechnology-based drug delivery systems for the kidney F Oroojalian, F Charbgoo, M Hashemi, A Amani, R Yazdian-Robati, ... Journal of controlled release 321, 442-462, 2020	153	2020
Aptasensors for quantitative detection of kanamycin RY Robati, A Arab, M Ramezani, FA Langroodi, K Abnous, SM Taghdisi Biosensors and Bioelectronics 82, 162-172, 2016	145	2016
Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo SM Taghdisi, NM Danesh, M Ramezani, P Lavaee, SH Jalalian, ... European Journal of Pharmaceutics and Biopharmaceutics 102, 152-158, 2016	135	2016
HER2-positive breast cancer immunotherapy: a focus on vaccine development A Arab, R Yazdian-Robati, J Behravan Archivum immunologiae et therapiae Experimentalis 68 (1), 2, 2020	82	2020
Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin SA Dorri, H Hosseinzadeh, K Abnous, FV Hasani, RY Robati, BM Razavi Iranian Journal of Basic Medical Sciences 18 (10), 958, 2015	81	2015
Kojic acid–natural product conjugates as mushroom tyrosinase inhibitors M Ashooriha, M Khoshneviszadeh, M Khoshneviszadeh, A Rafiei, ... European Journal of Medicinal Chemistry 201, 112480, 2020	79	2020
A novel AS1411 aptamer-based three-way junction pocket DNA nanostructure loaded with doxorubicin for targeting cancer cells in vitro and in vivo SM Taghdisi, NM Danesh, M Ramezani, R Yazdian-Robati, K Abnous Molecular pharmaceutics 15 (5), 1972-1978, 2018	77	2018
Aptasensors for quantitative detection of Salmonella Typhimurium N Ansari, R Yazdian-Robati, M Shahdordizadeh, Z Wang, K Ghazvini Analytical biochemistry 533, 18-25, 2017	69	2017
Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs M Hashemi, A Shamshiri, M Saeedi, L Tayebi, R Yazdian-Robati Archives of biochemistry and biophysics 691, 108485, 2020	67	2020
Proteomics and phosphoproteomics analysis of liver in male rats exposed to bisphenol A: Mechanism of hepatotoxicity and biomarker discovery FV Hassani, K Abnous, S Mehri, A Jafarian, R Birner-Gruenberger, ... Food and Chemical Toxicology 112, 26-38, 2018	60	2018
Acute toxicity of functionalized single wall carbon nanotubes: a biochemical, histopathologic and proteomics approach H Ahmadi, M Ramezani, R Yazdian-Robati, B Behnam, KR Azarkhiavi, ... Chemico-Biological Interactions 275, 196-209, 2017	56	2017
A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells A Bahreyni, R Yazdian-Robati, S Hashemitabar, M Ramezani, ... International Journal of Pharmaceutics 526 (1-2), 391-399, 2017	53	2017
Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence P Bayat, M Farshchi, M Yousefian, M Mahmoudi, R Yazdian-Robati International Immunopharmacology, 2021	51	2021
Doxorubicin delivery via magnetic nanomicelles comprising from reduction-responsive poly (ethylene glycol)‑b‑poly (ε‑caprolactone)(PEG-SS-PCL) and loaded with superparamagnetic … SD Mousavi, F Maghsoodi, F Panahandeh, R Yazdian-Robati, ... Materials Science and Engineering: C 92, 631-643, 2018	49	2018
Fluorometric aptasensing of the neonicotinoid insecticide acetamiprid by using multiple complementary strands and gold nanoparticles A Bahreyni, R Yazdian-Robati, M Ramezani, K Abnous, SM Taghdisi Microchimica Acta 185, 1-7, 2018	46	2018
Application of aptamers in treatment and diagnosis of leukemia R Yazdian-Robati, A Arab, M Ramezani, K Abnous, SM Taghdisi International journal of pharmaceutics 529 (1-2), 44-54, 2017	46	2017
Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System *in vitro* and *in vivo* R Yazdian-Robati, M Ramezani, SH Jalalian, K Abnous, SM Taghdisi Pharmaceutical research 33, 2289-2297, 2016	46	2016
An aptamer for recognizing the transmembrane protein PDL-1 (programmed death-ligand 1), and its application to fluorometric single cell detection of human ovarian carcinoma cells R Yazdian-Robati, M Ramezani, M Khedri, N Ansari, K Abnous, ... Microchimica Acta 184, 4029-4035, 2017	42	2017
Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo R Yazdian-Robati, A Arab, M Ramezani, H Rafatpanah, A Bahreyni, ... Drug development and industrial pharmacy 45 (4), 603-610, 2019	41	2019

Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.

Artikkelit 1–20

Sitaatteja vuodessa

Päällekkäiset lähteet

Yhdistetyt sitaatit

Lisää muut kirjoittajatMuut kirjoittajat

Seuraa

Viittaukset

Muut kirjoittajat